Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year PDF $40.00
$40.00
× Placeholder Integrating Primary Care Services Into Psychiatric Care Settings: A Review of the Literature PDF $40.00
$40.00
× Placeholder 1-Year Follow-Up of Patients Treated With Risperidone and Topiramate for a Manic Episode PDF $40.00
$40.00
× Placeholder Spontaneous Social Behaviors Discriminate Behavioral Dementias From Psychiatric Disorders and Other Dementias PDF $40.00
$40.00
× Placeholder A Randomized Trial Comparing Paroxetine and Venlafaxine in the Treatment of Bipolar Depressed Patients Taking Mood Stabilizers PDF $40.00
$40.00
× Placeholder Trauma at the Hands of Another: Distinguishing PTSD Patterns Following Intimate and Nonintimate Interpersonal and Noninterpersonal Trauma in a Nationally Representative Sample PDF $40.00
$40.00
× Placeholder A Prospective, Naturalistic, Blinded Study of Early Neurobehavioral Outcomes for Infants Following Prenatal Antidepressant Exposure PDF $40.00
$40.00
× Placeholder A Double-Blind Study of Long-Term Treatment With Sertraline or Fluvoxamine for Prevention of Highly Recurrent Unipolar Depression PDF $40.00
$40.00
× Placeholder Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis PDF $40.00
$40.00
× Placeholder Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis PDF $40.00
$40.00
× Placeholder Predictors of Nonadherence to Continuation and Maintenance Antidepressant Medication in Patients With Remitted Recurrent Depression PDF $40.00
$40.00
× Placeholder Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder PDF $40.00
$40.00
× Placeholder Prognostic Subgroups for Remission, Response, and Treatment Continuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Trial PDF $40.00
$40.00
× Placeholder Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder: An Open-Label Trial Followed by a Double-Blind Discontinuation Phase PDF $40.00
$40.00
× Placeholder Guided Discontinuation Versus Maintenance Treatment in Remitted First-Episode Psychosis: Relapse Rates and Functional Outcome PDF $40.00
$40.00
× Placeholder Seasonal Surge for Mental Health Demand in Emergency Departments PDF $40.00
$40.00
× Placeholder The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms PDF $40.00
$40.00
× Placeholder The Clinician’s Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia PDF $40.00
$40.00
× Placeholder A Case-Control Study of Antidepressants and Attempted Suicide During Early Phase Treatment of Major Depressive Episodes PDF $40.00
$40.00
× Placeholder Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study PDF $40.00
$40.00
× Placeholder Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial PDF $40.00
$40.00
× Placeholder Cigarette Smoking and the Onset and Persistence of Panic Attacks During Mid-Adulthood in the United States: 1994-2005 PDF $40.00
$40.00
× Placeholder Long-Term Neurodevelopmental Outcomes in Children and Adolescents With Congenital Heart Disease PDF $40.00
$40.00
× Placeholder Association of Recent and Past Suicide Attempts With Health-Related Quality of Life PDF $40.00
$40.00
× Placeholder Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression PDF $40.00
$40.00
× Placeholder Axis I Dissociative Disorder Comorbidity in Borderline Personality Disorder and Reports of Childhood Trauma PDF $40.00
$40.00
× Placeholder Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder PDF $40.00
$40.00
× Placeholder Prevalence and Predictors of Type 2 Diabetes Mellitus in People With Bipolar Disorder: A Systematic Review and Meta-Analysis PDF $40.00
$40.00
× Placeholder Preliminary Observations on the Effectiveness of Levetiracetam in the Open Adjunctive Treatment of Refractory Bipolar Disorder PDF $40.00
$40.00
× Placeholder Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response: A Naturalistic Study PDF $40.00
$40.00
× Placeholder Schizophrenia-Like Psychosis in a Temporal Lobe Epilepsy Patient Following a Right Temporal Lobectomy PDF $40.00
$40.00
× Placeholder Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder PDF $40.00
$40.00
× Placeholder Differential Diagnosis of Anterograde Amnesia From Bilateral Hippocampal Ischemia Due to Opiate Intoxication PDF $40.00
$40.00
× Placeholder Efficacy of Motivational Interviewing in Treating Co-occurring Psychosis and Substance Use Disorder: A Systematic Review and Meta-Analysis PDF $40.00
$40.00
× Placeholder Mild Cognitive Impairment: Clinical Presentation and Short-Term Comparative Outcome of Patients With Potentially Modifiable and Nonmodifiable Risk Factors PDF $40.00
$40.00
× Placeholder Clinical Utility of Early Improvement to Predict Response or Remission in Acute Mania: Focus on Olanzapine and Risperidone PDF $40.00
$40.00
× Placeholder Pharmacologic Treatment of Postpartum Women With New-Onset Major Depressive Disorder: A Randomized Controlled Trial With Paroxetine PDF $40.00
$40.00
× Placeholder The Management of Alcohol Use Disorders: The Impact of Pharmacologic, Affective, Behavioral, and Cognitive Approaches PDF $40.00
$40.00
× Placeholder Hippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up PDF $40.00
$40.00
× Placeholder BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,600.00
Total $1,600.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe